Understanding how cell death affects glioblastoma growth

The role and mechanism of necrosis in glioblastoma

NIH-funded research Pennsylvania State Univ Hershey Med Ctr · NIH-11019857

This study is looking at how a specific type of cell death affects the growth of glioblastoma, a tough brain tumor, and aims to find new treatment options that could help patients by understanding what makes these tumors behave the way they do.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr NIH-funded
Lab location1 site (Hershey, United States)
Project IDNIH-11019857 on NIH RePORTER

What this research studies

This research investigates the role of necrosis, a form of cell death, in glioblastoma, the most aggressive type of brain tumor. By studying mouse models and patient samples, the researchers aim to understand how the necrotic environment influences tumor progression and the differentiation of the most malignant glioblastoma subtype. The project focuses on identifying specific mechanisms, such as ferroptosis, that could be targeted for new therapies. Patients may benefit from insights that could lead to more effective treatments tailored to the unique characteristics of their tumors.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma, particularly those with the mesenchymal subtype.

Not a fit: Patients with other types of brain tumors or those who do not have glioblastoma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new targeted therapies for glioblastoma that improve patient outcomes.

How similar studies have performed: Previous research has shown promising results in targeting tumor microenvironments in glioblastoma, suggesting potential for success in this approach.

Where this research is happening

Hershey, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions cancer microenvironmentcancer progression
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.